 |
 |
 |
|
Real-World Adherence and Persistence with Cabotegravir + Rilpivirine Long Acting (CAB + RPV LA) compared with Oral ART among PWH in the US: The ABOVE Study
|
|
|
Cindy Garris
ViiV Healthcare
12 October-2023
Cindy Garris1, Raj Desai2, Rose Chang2, Louise Clear2, Zhuo Chen2, Daisy Liu2, Maral DerSarkissian2, Paula Teichner1, Edgar T. Overton1
1 ViiiV Healthcare
2 Analysis Group, Inc.







|
|
|
 |
 |
|
|